Skip to main content

Advertisement

Table 2 Association of complications with the age of the respondents

From: Medication utilization pattern for management of pregnancy complications: a study in Western Nepal

Complications Age of the respondents (in years) (n,%) Total p value
15–19 years 20–24 years 25–29 years 30–34 years 35–39 years 40–44 years
Acid reflux disease 1 (5) 12 (60) 5 (25) 2 (10) 0 0 20 (100) 0.988
Anemia 0 1 (100) 0 0 0 0 1 (100)
Anxiety 0 1 (50) 0 1 (50) 0 0 2 (100)
Asthma 0 2 (66.7) 1 (33.3) 0 0 0 3 (100)
Constipation 0 2 (50) 2 (50) 0 0 0 4 (100)
Depression 0 0 0 1 (100) 0 0 1 (100)
Diabetes mellitus 0 0 0 1 (100) 0 0 1 (100)
Diarrhea 0 0 2 (66.7) 1 (33.3) 0 0 3 (100)
Dry eye 0 1 (100) 0 0 0 0 1 (100)
Edema 0 5 (55.6) 2 (22.2) 1 (11.1) 1 (11.1) 0 9 (100)
Epilepsy 0 2 (100) 0 0 0 0 2 (100)
Fever/Headache 3 (30) 4 (40) 3 (30) 0 0 0 10 (100)
Hyperemesis gravidarum 0 2 (40) 3 (60) 0 0 0 5 (100)
Hypothyroidism 0 3 (60) 1 (20) 1 (20) 0 0 5 (100)
Irritable bowel disease 0 0 1 (100) 0 0 0 1 (100)
Itching 1 (14.3) 1 (14.3) 4 (57.1) 1 (14.3) 0 0 7 (100)
Loss of appetite 0 0 1 (50) 1 (50) 0 0 2 (100)
Loss of pregnancy 2 (22.2) 3 (33.3) 2 (22.2) 2 (22.2) 0 0 9 (100)
Nausea/Vomiting 9 (22.5) 16 (40) 14 (35) 1 (2.5) 0 0 40 (100)
Oligohydramnios 0 0 1 (100) 0 0 0 1 (100)
Pain 8 (11.9) 31 (46.3) 19 (28.4) 8 (11.9) 0 1 (1.5) 67 (100)
Pituitary adenoma 0 0 1 (100) 0 0 0 1 (100)
Pneumonia 0 0 1 (100) 0 0 0 1 (100)
Polyhrdramnios 0 0 1 (100) 0 0 0 1 (100)
Preeclampsia 1 (16.7) 2 (33.3) 2 (33.3) 1 (16.7) 0 0 6 (100)
Psychosis 1 (100) 0 0 0 0 0 1 (100)
PV bleeding 1 (7.1) 9 (64.3) 2 (14.3) 2 (14.3) 0 0 14 (100)
PV discharge 1 (12.5) 4 (50) 3 (37.5) 0 0 0 8 (100)
Thrombocytopenia 0 0 1 (100) 0 0 0 1 (100)
Tingling sensation 0 1 (50) 0 1 (50) 0 0 2 (100)
Total 34 (12.4) 121 (44) 90 (32.7) 27 (9.8) 2 (0.7) 1 (0.4) 275 (100)
Tuberculosis 0 0 1 (100) 0 0 0 1 (100)
Upper respiratory tract infection 5 (20.8) 7 (29.2) 11 (45.8) 1 (4.2) 0 0 24 (100)
Urinary tract infection 1 (5.3) 10 (52.6) 6 (31.6) 1 (5.3) 1 (5.3) 0 19 (100)
Weakness 0 2 (100) 0 0 0 0 2 (100)